Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines—data from the POLish Atrial Fibrillation (POL-AF) Registry-Reference-Cited by-同舟云学术

Antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention, including compliance with current guidelines—data from the POLish Atrial Fibrillation (POL-AF) Registry

Published:2021-02 Issue:1 Volume:11 Page:14-27
ISSN:2223-3652
Container-title:Cardiovascular Diagnosis and Therapy
language:
Short-container-title:Cardiovasc Diagn Ther

Author:

Uziębło-Życzkowska Beata,Krzesiński Paweł,Maciorowska Małgorzata,Gorczyca Iwona,Jelonek Olga,Wójcik Maciej,Błaszczyk Robert,Kapłon-Cieślicka Agnieszka,Gawałko Monika,Tokarek Tomasz,Rajtar-Salwa Renata,Bil Jacek,Wojewódzki Michał,Szpotowicz Anna,Krzciuk Małgorzata,Bednarski Janusz,Bakuła-Ostalska Elwira,Tomaszuk-Kazberuk Anna,Szyszkowska Anna,Wełnicki Marcin,Mamcarz Artur,Wożakowska-Kapłon Beata

Publisher

AME Publishing Company

Subject

Cardiology and Cardiovascular Medicine

Link

https://cdt.amegroups.com/article/download/61522/pdf

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An observational study of therapeutic procedures and in-hospital outcomes among patients admitted for acute myocardial infarction in Spain, 2016–2022: the role of diabetes mellitus;Cardiovascular Diabetology;2024-08-24

2. Association of Body Mass Index with Outcomes in Patients with Atrial Fibrillation: Analysis from the (JoFib) Registry;Vascular Health and Risk Management;2024-03

3. Worsening Renal Function and Adverse Outcomes in Patients with HFpEF with or without Atrial Fibrillation;Biomedicines;2023-09-07

4. Molecular Docking Study of Crocetin with Interleukin–18 for the Treatment of Atrial Fibrillation;CARDIOMETRY;2022-11-30

5. The Value of Rivaroxaban Combined with Ticagrelor in Antithrombotic Therapy after PCI in Patients with Nonvalvular Atrial Fibrillation with Acute Coronary Syndrome;Evidence-Based Complementary and Alternative Medicine;2022-11-03